These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 10777191

  • 1. Azathioprine and 6-mercaptopurine for the treatment of perianal Crohn's disease in children.
    Jeshion WC, Larsen KL, Jawad AF, Piccoli DA, Verma R, Maller ES, Baldassano RN.
    J Clin Gastroenterol; 2000 Apr; 30(3):294-8. PubMed ID: 10777191
    [Abstract] [Full Text] [Related]

  • 2. Predictive factors of response of perianal Crohn's disease to azathioprine or 6-mercaptopurine.
    Lecomte T, Contou JF, Beaugerie L, Carbonnel F, Cattan S, Gendre JP, Cosnes J.
    Dis Colon Rectum; 2003 Nov; 46(11):1469-75. PubMed ID: 14605564
    [Abstract] [Full Text] [Related]

  • 3. Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn's disease.
    Dejaco C, Harrer M, Waldhoer T, Miehsler W, Vogelsang H, Reinisch W.
    Aliment Pharmacol Ther; 2003 Dec; 18(11-12):1113-20. PubMed ID: 14653831
    [Abstract] [Full Text] [Related]

  • 4. Combining infliximab with 6-mercaptopurine/azathioprine for fistula therapy in Crohn's disease.
    Ochsenkühn T, Göke B, Sackmann M.
    Am J Gastroenterol; 2002 Aug; 97(8):2022-5. PubMed ID: 12190171
    [Abstract] [Full Text] [Related]

  • 5. Combination therapy with oral tacrolimus (FK506) and azathioprine or 6-mercaptopurine for treatment-refractory Crohn's disease perianal fistulae.
    Lowry PW, Weaver AL, Tremaine WJ, Sandborn WJ.
    Inflamm Bowel Dis; 1999 Nov; 5(4):239-45. PubMed ID: 10579116
    [Abstract] [Full Text] [Related]

  • 6. Use of endoscopic ultrasound to guide combination medical and surgical therapy for patients with Crohn's perianal fistulas.
    Schwartz DA, White CM, Wise PE, Herline AJ.
    Inflamm Bowel Dis; 2005 Aug; 11(8):727-32. PubMed ID: 16043987
    [Abstract] [Full Text] [Related]

  • 7. Role of immunosuppressives in special situations: perianal disease and postoperative period.
    Ghosh S, Iacucci M.
    Dig Dis; 2014 Aug; 32 Suppl 1():92-5. PubMed ID: 25531359
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine.
    Bouhnik Y, Lémann M, Mary JY, Scemama G, Taï R, Matuchansky C, Modigliani R, Rambaud JC.
    Lancet; 1996 Jan 27; 347(8996):215-9. PubMed ID: 8551879
    [Abstract] [Full Text] [Related]

  • 12. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM.
    Dan Med Bull; 2011 Dec 27; 58(12):B4360. PubMed ID: 22142578
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Concomitant use of azathioprine/6-mercaptopurine decreases the risk of anti-TNF-induced skin lesions.
    Soh JS, Yun WJ, Kim KJ, Won CH, Park SH, Yang DH, Ye BD, Byeon JS, Myung SJ, Yang SK, Kim JH.
    Inflamm Bowel Dis; 2015 Apr 27; 21(4):832-9. PubMed ID: 25789922
    [Abstract] [Full Text] [Related]

  • 16. Impact of timing and duration of thiopurine treatment on first perianal surgery in Crohn's disease: UK population-based study (1995-2009).
    Chhaya V, Saxena S, Cecil E, Subramanian V, Curcin V, Majeed A, Pollok RC.
    Inflamm Bowel Dis; 2015 Feb 27; 21(2):385-91. PubMed ID: 25569740
    [Abstract] [Full Text] [Related]

  • 17. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Prefontaine E, Macdonald JK, Sutherland LR.
    Cochrane Database Syst Rev; 2009 Oct 07; (4):CD000545. PubMed ID: 19821270
    [Abstract] [Full Text] [Related]

  • 18. Discordant erythrocyte sedimentation rate and C-reactive protein in children with inflammatory bowel disease taking azathioprine or 6-mercaptopurine.
    Barnes BH, Borowitz SM, Saulsbury FT, Hellems M, Sutphen JL.
    J Pediatr Gastroenterol Nutr; 2004 May 07; 38(5):509-12. PubMed ID: 15097439
    [Abstract] [Full Text] [Related]

  • 19. Tioguanine in patients with Crohn's disease intolerant or resistant to azathioprine/mercaptopurine.
    Bonaz B, Boitard J, Marteau P, Lémann M, Coffin B, Flourié B, Belaiche J, Cadiot G, Metman EH, Cortot A, Colombel JF, Getaid.
    Aliment Pharmacol Ther; 2003 Aug 15; 18(4):401-8. PubMed ID: 12940925
    [Abstract] [Full Text] [Related]

  • 20. Use of 6-mercaptopurine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease: pro.
    Hyams JS.
    Inflamm Bowel Dis; 2005 Feb 15; 11(2):197-9. PubMed ID: 15677914
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.